ALB and bacterial infectious disease: Prior to the initiation of the specific treatment with vasoactive drugs, the algorithm of the management of AKI requires that all medication taken by the patient be reviewed, with the withdrawal of all potential nephrotoxic drugs, including diuretics, non-selective betablockers, or non-steroidal anti-inflammatory drugs (NSAIDs); early recognition and treatment of bacterial infections, as well as plasma volume expansion with albumin, are also required [7].